GlaxoSmithKline: Theravance split in two will be an opportunity for GSK

NEUTRAL, Fair Value  1790p (+6%)

News published on April Friday 26, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities